Good day Pro Private Equity peeps! The private-equity industry has grown accustomed to legal and regulatory scrutiny over the past decade on a range of fronts, from registration with the Securities and Exchange Commission to investor disclosures, taxes and in some parts of the world, how they report on sustainability. Here in the U.S., some private-equity backers of healthcare companies are finding themselves facing legal action under the False Claims Act, as WSJ Pro Private Equity’s Chris Cumming reports today. Chris looks at a recent uptick in whistleblower settlements that private-equity firms have agreed to over the...
PORTLAND, Ore. - Two men face federal charges for allegedly defrauding Medicare, the Department of Health and Human Services, the Veterans Health Administration and private insurance companies out...